{"name":"USRC Kidney Research","slug":"usrc-kidney-research","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Hematology","slug":"hematology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Ferric Citrate 1 GM Oral Tablet [AURYXIA]","genericName":"Ferric Citrate 1 GM Oral Tablet [AURYXIA]","slug":"ferric-citrate-1-gm-oral-tablet-auryxia","indication":"Hyperphosphatemia in patients with chronic kidney disease on dialysis","status":"phase_3"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Ferric Citrate 1 gram Oral Tablet","genericName":"Ferric Citrate 1 gram Oral Tablet","slug":"ferric-citrate-1-gram-oral-tablet","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Ferric Citrate 1 GM Oral Tablet [AURYXIA]","genericName":"Ferric Citrate 1 GM Oral Tablet [AURYXIA]","slug":"ferric-citrate-1-gm-oral-tablet-auryxia","phase":"phase_3","mechanism":"Ferric citrate binds phosphate in the gastrointestinal tract to reduce serum phosphate levels in patients with chronic kidney disease.","indications":["Hyperphosphatemia in patients with chronic kidney disease on dialysis","Iron deficiency anemia in patients with chronic kidney disease"],"catalyst":""},{"name":"Ferric Citrate 1 gram Oral Tablet","genericName":"Ferric Citrate 1 gram Oral Tablet","slug":"ferric-citrate-1-gram-oral-tablet","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxOQm95WnVpcXNwTzNfR0RnMWxMdWlDZmhkVC1uUHM2QXFocHF2M3hqOXp6RmU1cnRvcEtYTUw1cDNrQzBjVTlHZ0xWQmpHR3dJdEpNLVpOaVhXMUtJRDE1X2ZvXzFLUHNmZ3ZvU2NtZ1hBQ1B1ZVpXOF9zY2JGY3Vydi1rNEpsUHdtWnI0LWszU2hxbWo0cExORkdtME9iRjJqUnVYS2c1anNSYnlXSUJKVy1XaHUxZWh4bnYzV1lR?oc=5","date":"2026-03-17","type":"pipeline","source":"Fierce Biotech","summary":"R1 zooms out of stealth with $77.5M series A to advance chronic kidney disease treatment - Fierce Biotech","headline":"R1 zooms out of stealth with $77.5M series A to advance chronic kidney disease treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxPYUVKWGtHdUtUOVdFbzREMmNmWjhYRW8yWXFORGNjWlh4SFBnQjdXVUlXckI3ZVp5QTFkdFVUR0hqUTM2RmxaZ0hmV2ZUenVkclNGdlVvZUhCb2dYMFpyZmhxY3pZMVphUU9WckdSWUZSLUJuTzc5VW9sVHJ3Y00yVlR0VnBwZ0ZhblZZcHN4OHZVZDRibnfSAZsBQVVfeXFMTXJUSmk5b2tfemlSZm5tNkR2Ty1jSXBYWEFud3ZaSVlVMVBCa3VCdWVQSExXZFBXQ0F5RFdCSG1JRXpteHVKQUNCMzdsazBpVGpzeGotdTZzTHpJZS1QNEstWTZvTDRvWmVwNTg4a0xKVGpfcVRBcnpUdzVQUm9TTTlrelpmYnktd1NPUDBLV0duMVhMYnV3WjhkYVU?oc=5","date":"2026-03-17","type":"pipeline","source":"Pulse 2.0","summary":"R1 Therapeutics: $77.5 Million Raised To Advance Kidney Disease Treatment - Pulse 2.0","headline":"R1 Therapeutics: $77.5 Million Raised To Advance Kidney Disease Treatment - Pulse 2.0","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-03-17","type":"pipeline","source":"The Manila Times","summary":"R1 Therapeutics launches with oversubscribed $77.5 million Series A financing to advance first-in-class treatment for hyperphosphatemia in patients with chronic kidney disease - The Manila Times","headline":"R1 Therapeutics launches with oversubscribed $77.5 million Series A financing to advance first-in-class treatment for hy","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-03-17","type":"deal","source":"The Manila Times","summary":"Alebund Pharmaceuticals Announces Collaboration and License Agreement with R1 Therapeutics for AP306 - The Manila Times","headline":"Alebund Pharmaceuticals Announces Collaboration and License Agreement with R1 Therapeutics for AP306","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wJBVV95cUxNM1dSeXR4dlVucWZsbFVmUVV1RlMzUWxYX1AyOFVZQTNXSnpEMy13am9ZRGNwYXFXN0pFRmNILVNjSTc0TTNBZ3VsZk1YREczZFZnU3I3MVR3LThhcWREd3hleFlwdFpXRlducTU3X3VaTGlEazRFTXMzN0lHeFM5eU5fTy1NLWJ2TmZRN1BnOW9QWnQ2ZkQ4VUROVnZEOHRYdjU3Q2lra1pGa1dPNUx6bTd0N1MwVDB6UzRYeWc1dEtlaEdDWUR0d2lUYXhOSFg1NlZqTG5tVHRLTm44eG9DUFg3N08wT0hGZjl6ZUxGa3FleGcxZ1lkZWRtdS16SHh0d1h4QVZUbWVjSUFwdC1QbHFUM2xSWVl1NTdURVdoVlROVERvVl9KblZ3a0tXQkU0S1hLQ1ZOcExoQ3FMTkZnRkxLX2IxYlRJUW5aMkNrQ1hHSTQ?oc=5","date":"2025-11-10","type":"trial","source":"PR Newswire","summary":"Vexev's VxWave System Successfully Meets Clinical Endpoints in Landmark Study Evaluating Robotic Ultrasound Scanning for Mapping Vascular Access at U.S. Renal Care Dialysis Clinics - PR Newswire","headline":"Vexev's VxWave System Successfully Meets Clinical Endpoints in Landmark Study Evaluating Robotic Ultrasound Scanning for","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE4xd1ZQa0trYkhKdFJBUllJOFdGX3VnRjZHbG5zYWtRdG16VlRxamt0UUhQdHNPVVVyWFlJODZfWWFVLXBoOG1meGw3NWVVMmRBYU9TUk8tQUhiM2JPNU01b3BQNGZaOEhqQkJQY2RoMUllbnFHczQxS2FzMjA3dw?oc=5","date":"2025-07-29","type":"trial","source":"Yahoo Finance","summary":"Vexev and U.S. Renal Care Complete Enrollment in Groundbreaking Trial Evaluating Use of Robotic Ultrasound Scanning for AV Fistula Mapping in Dialysis Clinics - Yahoo Finance","headline":"Vexev and U.S. Renal Care Complete Enrollment in Groundbreaking Trial Evaluating Use of Robotic Ultrasound Scanning for ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxQN3lkejkyVXNSV2p1bTZNQTRyZEd3RGNmV2Q3OUJ4ZFdCQ09KSWVvaGt1aXVKbDFYRV81ampHOUVHem1oNzdLbWpLQ0xjWjZNdUYyZXlteGdYTDBheHNRSEx0SmtBbXFHU0NJMTBtS1lzVUIyX1lXWWM3S3VjQ0piSUoyVEdiN3I5S2FBOFI3bGhWd1FFampxUlN5SlJZTEI0NFhhaUQ5ejZoc3NjTHRvV19VU2h5dHVBQ0t6NXpEM2c0Y1NOc0M1T08wRkZlNHVSMG9iZVpyd0V2QUN0Snc?oc=5","date":"2025-02-13","type":"pipeline","source":"PR Newswire","summary":"U.S. Renal Care Announces New Program to Support Team Members in Becoming Nephrology Nurses - PR Newswire","headline":"U.S. Renal Care Announces New Program to Support Team Members in Becoming Nephrology Nurses","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwJBVV95cUxOcmlCZWVoOEw2ZFk4d3p4UjlfQmFQa3pIdi1nLTFyVTlFZWRzWDZ0QmM0Nnc3S0RrNWc2RjZvOWhmX1ZwYkZwNnEwMGdKRkZVLWp3OTNXdkZpcDlMOFR4TDFONmxjbGJVMlBWTWdWQkJfcVNKbnpLTXc3SkxoYVJPZ1dCSHdYa0JJN2dsVkdxeHpSM1U1N3RSWEdzY09kdF9NTEwzTGtmZEdYeVl2RExIVmEyZFNfbFhKYjlIbl9wMWpxT1VQbmNMLTdsMXNDTHk1VXY1Y1JWY3RLbGIweWtpQkVuVHJoWTFUNklGWFNqX3JnOXdFVnZDdkxYazRNVllpN0tXTWVTNng2MEJfbWxKVGM3MA?oc=5","date":"2024-12-03","type":"trial","source":"PR Newswire","summary":"U.S. Renal Care Enrolled First Patients in the VOICE Collaborative Clinical Trial of Vafseo® (vadadustat) for CKD Patients on Dialysis - PR Newswire","headline":"U.S. Renal Care Enrolled First Patients in the VOICE Collaborative Clinical Trial of Vafseo® (vadadustat) for CKD Patien","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwJBVV95cUxNSnotZnpsYm9hR01IQUN3S1EwdTJGNy1XamlCUEV0NVdKS0tvd0VlMlpVRmdudXhNcHQwckppUGpGdl9mOVlXV1ZRankzdk5TWlZwOUw4OElHT2dVQlRwWHZJRno2anhnZVNLeTlKcmszR2plblpubUR2b2Vja1docmJwZm42TzU5a0xsV00teXhCNjEwczRtTG04SHRGN0Zjb2U2Y1pqWFlPeGVaeUx5Vi1NVHR5Y01PQzdZSmR2RllRTTYzVm9xQWxCSGdvckpyQ0ltb2Z2TmNGcWVvcVQ3cUk1ZDNwMkJDVzlGRVRLRlFkLWJjaVVQSnVSVDhVVG9aUTVTcFJVVlNfcVNLRnMzRmVqQ3Y0Q1U?oc=5","date":"2024-10-07","type":"pipeline","source":"PR Newswire","summary":"Akebia Therapeutics and U.S. Renal Care Sign Commercial Supply Contract to Enable Access to Vafseo® (vadadustat) for Patients on Dialysis - PR Newswire","headline":"Akebia Therapeutics and U.S. Renal Care Sign Commercial Supply Contract to Enable Access to Vafseo® (vadadustat) for Pat","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxNdlhIV2M3UGFWd0w0SHpaMHl4WWxQNDRQd2prVHJlSzlLZzJuTlRZd1pyUVhlVkFHcV9xS0ZsY25yVmU3T194UmF5bnQ4UVNwYm11NDBiQVJYWElXZXQ5NWlxa1lEVllGenB1X1pHOTQxTDBGRTk4R0gxYXVrX3Z2MlVWT0NLTVUtY3djSlRyeEdDLWdMa09fLUZRMTFsendSR2ZKbEsxTkNocmM2UHRuMzRoSXM4RFctdkE?oc=5","date":"2023-12-13","type":"pipeline","source":"PR Newswire","summary":"Kidneylink Announces Program Growth in Value-Based Kidney Care - PR Newswire","headline":"Kidneylink Announces Program Growth in Value-Based Kidney Care","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxQcGhqaWVJWjBIRlhDUlFPRU4zQkhIVzc1Mnpud2d0VGxTWEF0Wmt6NVpvSEZBR2RVQkc5WjcxX0tfOHhZQjB5aVNrSWdPQ0k2UkdaSFI4X1NQcDZNcXlLdF9haDJfS3NFaDJmUDRXdERhUERqVW5pUGlNazZUVjg4ZA?oc=5","date":"2021-08-19","type":"pipeline","source":"Fortune Business Insights","summary":"U.S. Dialysis Services Market Size, Share | Growth Report [2032] - Fortune Business Insights","headline":"U.S. Dialysis Services Market Size, Share | Growth Report [2032]","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_3":1,"marketed":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}